Viridian Therapeutics, Inc. · NASDAQ:VRDN

Bellevue Group AG reported a 6.60% stake in Viridian Therapeutics, Inc. (Schedule 13G)

Event Mar 31, 2026 · Filed May 15, 2026

Bellevue Group AG reported a 6.60% stake in Viridian Therapeutics, Inc., 6,726,144 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G).

Stake
6.60%
Shares
6,726,144
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Bellevue Group AG6.60%6,726,144
Bellevue Asset Management AG6.60%6,726,144

Source

View original at SEC

Related